BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$484M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$450M |
| 3 |
UnitedHealth
UNH
|
+$430M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
Analog Devices
ADI
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$552M |
| 3 |
Netflix
NFLX
|
+$322M |
| 4 |
PepsiCo
PEP
|
+$291M |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.39% |
| 2 | Financials | 8.43% |
| 3 | Healthcare | 8.12% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOUS
3876
DELISTED
Anywhere Real Estate
HOUS
| $97.1K | ﹤0.01% |
29,163
-109,470
| -79% | -$388K |
|
3877
Utah Medical Products
UTMD
$226M
| $96.8K | ﹤0.01% |
1,728
-3,184
| -65% | -$191K |
|
3878
MidCap Financial Investment
MFIC
$803M
| $96.5K | ﹤0.01% |
7,507
-2,502
| -25% | -$34K |
|
|
REVG
3879
DELISTED
REV Group
REVG
| $96K | ﹤0.01% |
3,039
-8,459
| -74% | -$274K |
|
3880
PUT
AstraZeneca
AZN
$243B
| $95.5K | ﹤0.01% |
+7
| New | +$1.01K |
|
3881
Astrana Health
ASTH
$2.02B
| $95.5K | ﹤0.01% |
3,080
-2,558
| -45% | -$85.2K |
|
3882
Carter Bankshares
CARE
$757M
| $95.4K | ﹤0.01% |
5,896
-5,264
| -47% | -$90.3K |
|
3883
TFS Financial
TFSL
$4.95B
| $95.2K | ﹤0.01% |
7,684
+5,208
| +210% | +$66.7K |
|
3884
Teekay Tankers
TNK
$2.95B
| $93.9K | ﹤0.01% |
2,453
-1,149
| -32% | -$46.5K |
|
3885
Rigetti Computing
RGTI
$6.28B
| $93.9K | ﹤0.01% |
11,850
-8,881
| -43% | -$98.5K |
|
3886
Knowles
KN
$3.29B
| $93.8K | ﹤0.01% |
6,172
-8,186
| -57% | -$147K |
|
3887
Kymera Therapeutics
KYMR
$9.76B
| $93.5K | ﹤0.01% |
3,417
-6,421
| -65% | -$234K |
|
3888
MasterCraft Boat Holdings
MCFT
$605M
| $93.5K | ﹤0.01% |
5,427
+3,262
| +151% | +$59.2K |
|
3889
Nelnet
NNI
$4.57B
| $93.3K | ﹤0.01% |
841
-858
| -51% | -$96.1K |
|
3890
Arlo Technologies
ARLO
$1.54B
| $93K | ﹤0.01% |
9,426
-25,966
| -73% | -$296K |
|
3891
Smith-Midland
SMID
$150M
| $92.7K | ﹤0.01% |
2,983
+1,365
| +84% | +$50.3K |
|
3892
CG Oncology
CGON
$6.65B
| $92.5K | ﹤0.01% |
3,779
-1,857
| -33% | -$52.2K |
|
3893
Sierra Bancorp
BSRR
$532M
| $92.3K | ﹤0.01% |
3,309
-9,238
| -74% | -$273K |
|
3894
Orion
OEC
$364M
| $91.8K | ﹤0.01% |
7,103
-18,095
| -72% | -$256K |
|
3895
Akebia Therapeutics
AKBA
$242M
| $91.7K | ﹤0.01% |
47,774
+13,175
| +38% | +$26.9K |
|
3896
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
| $91.7K | ﹤0.01% |
+1,382
| New | +$94.7K |
|
3897
Resources Connection
RGP
$145M
| $91.1K | ﹤0.01% |
13,931
-59,274
| -81% | -$460K |
|
|
KREF
3898
KKR Real Estate Finance Trust
KREF
$490M
| $91K | ﹤0.01% |
8,424
-12,757
| -60% | -$137K |
|
3899
iShares MSCI France ETF
EWQ
$332M
| $90.8K | ﹤0.01% |
2,281
-6,190
| -73% | -$243K |
|
3900
4D Molecular Therapeutics
FDMT
$637M
| $90.3K | ﹤0.01% |
27,966
-67,458
| -71% | -$318K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2025 Portfolio in Review
As of Q1 2025, BNP Paribas Financial Markets held 5,672 positions worth $170B, down 4.7% from $178B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets's Q1 2025 filing shows 266 new, 2,026 increased, 2,595 reduced and 297 closed positions. Its largest new stake was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.79B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- BNP Paribas Financial Markets's largest Q1 2025 buy was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M.
- BNP Paribas Financial Markets added most to iShares MSCI USA Quality Factor ETF in Q1 2025, an estimated $484M increase.
- BNP Paribas Financial Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.79B.
- BNP Paribas Financial Markets fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q1 2025, selling an estimated $83.2M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $170B portfolio in Q1 2025.
- BNP Paribas Financial Markets opened 266 new positions and closed 297 in Q1 2025.
- BNP Paribas Financial Markets's portfolio value fell 4.7% quarter-over-quarter to $170B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.